DCST2 inhibitors belong to a specific class of chemical compounds designed to target and modulate the activity of DCST2, also known as dendritic cell-specific transmembrane protein 2. DCST2 is a transmembrane protein that plays a crucial role in various cellular processes, particularly in the context of immune function and antigen presentation. The inhibitors within this class are meticulously designed molecules that interact with DCST2, typically at the molecular level, to influence its function. These compounds are characterized by their specific molecular structures and properties that enable them to selectively bind to DCST2, interfering with its activity or expression.
DCST2 inhibitors is carefully engineered to ensure a high degree of specificity for their target protein. This specificity is essential to minimize off-target effects and potential toxicity. Typically, DCST2 inhibitors possess molecular features that allow them to interact with key binding sites on the DCST2 protein, disrupting its normal function. These inhibitors can be synthesized using various chemical synthesis techniques, with their effectiveness often relying on their ability to compete with endogenous molecules or ligands that would normally bind to DCST2.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Vioxx | 162011-90-7 | sc-208486 | 100 mg | $190.00 | 3 | |
A selective inhibitor of COX-2 that interacts with the COX-2 enzyme's heme group, reducing its activity. | ||||||
Etoricoxib | 202409-33-4 | sc-218446 | 10 mg | $36.00 | 3 | |
Selectively binds to the COX-2 enzyme, inhibiting its action and the subsequent production of inflammatory prostaglandins. | ||||||
Lumaricoxib | 220991-20-8 | sc-205736 sc-205736A | 100 mg 250 mg | $140.00 $280.00 | ||
Binds with COX-2 selectively, resulting in the decreased formation of inflammatory prostaglandins. | ||||||
Cimicoxib | 265114-23-6 | sc-501410 | 25 mg | $380.00 | ||
A veterinary COX-2 inhibitor that selectively binds to and inactivates the COX-2 isoenzyme. | ||||||
Diclofenac acid | 15307-86-5 | sc-357332 sc-357332A | 5 g 25 g | $109.00 $298.00 | 5 | |
Though not highly selective, it preferentially inhibits COX-2 over COX-1, reducing prostaglandin synthesis. | ||||||
Meloxicam | 71125-38-7 | sc-200626 sc-200626A sc-200626B | 20 mg 100 mg 500 mg | $36.00 $94.00 $156.00 | 3 | |
Preferentially inhibits COX-2, which is involved in the synthesis of inflammatory prostaglandins. | ||||||